维普中文期刊产品整合服务
54篇 您的检索式:作者名="Franz DN"
    题名 作者 年代 出处 被引量
1Efficacy and safcty of everolimus for subependymal giant cell astrocytomas associated with mberous sclerosis complex (EXIST-1):a multicentre,randomised,placebo-controlled phasc 3 trial显示文摘Franz DN Bclousova E Sparagana S 0,,9861:1
2Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex(EXIST-1):a multicentre,randomised,placebo-controlled phase 3trial显示文摘Franz DN Belousova E Sparagana S 2013Lancet2013,381,9861:1
3Efficacy and safety of everolimus for sub ependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST -I) : a multicentre, randomised, placebo-controlled phase 3 trial 显示文摘FRANZ DN BELOUSOVA E SPARAGANA S 2012Lancet2012,381,9861:1
4Current management of tuberous sclerosis com- plex显示文摘Krueger DA Franz DN 2008Paediatr Drugs2008,10,5:1
5Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex显示文摘Franz DN 2013Biologics2013,7,:1
6Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis显示文摘Franz DN Brody A Meyer C 0,,:1
7Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs 显示文摘Dabora SL Jozwiak S Franz DN 2001Am J Hum Genet2001,68,1:1
8Efficacyand safely of everolimus for subependymal giant cell astrocytomasassociated with tuberous sclerosis complex ( EX1ST-1 ) : a multi-centre ,randomised , placebo-controlled phase 3 trial 显示文摘FRANZ DN BKLOUSOVA E SPARAGANA S 2012Iaiii-cet2012,381,9861:1
9Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs显示文摘Dabora Sir Jozwiak S Franz DN 2001Am J Hum Genet2001,68,1:1
10Cardiac complications in pediatric patients on the ketogenic diet 显示文摘Best TH Franz DN Gilbert DL 2000Neurology2000,54,12:1
11Efficacy and safety of everolimus for subependymal siant cell astrocytomas associated with tuberous sclerosis complex( EXIST-1 ) : a muhicentre, randomised,pla- cebo-controlled phase 3 trial显示文摘Franz DN Belousova E Sparagana S 2013Lancet2013,381,9861:1
12Everolimus in the treatment of subependymal giant cell astrocytomas,angiomyolipomas,and pulmonary and skin lesions associated with tuberous sclerosis complex 显示文摘Franz DN 2013Biologies2013,7,:1
13Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis 显示文摘Franz DN Brody A Meyer C 2001Am J Respir Crit Care Med2001,164,:1
14Tuberous sclerosis complex: neurological, renal and pulmonary manifestations 显示文摘Franz DN Bissler J J McCormack FX 2010Neuropediatrlcs2010,41,:1
15Mutational analysis in acohort of 224 tuberous sclerosis patients indicates increased severityof TSC2, compared with TSC1, disease in multiple organs显示文摘Dabora SL Jozwiak S Franz DN 2001Am JHum Genet2001,68,1:1
16Mutational analysis in a cohort of 224 tuberous sclersis patients indicates increased severity of TSC2 compared with TSC1,disease in multiple organs显示文摘Dabora SL Jozw iak S Franz DN 2001Am J Hum Genet2001,68,:1
17Tuberous sclerosis complex: neurological, renal and pulmonary manifestations 显示文摘Franz DN Bissler JJ McCormack FX 2010Neuropediat- rics2010,41,5:1
18Rapamycin causes regression of Astrocytomas in Tuberous Sclerosis complex 显示文摘Franz DN Leonard J Tudor C 2006Ann Neurol2006,59,3:1
19Mutational analysis in acohort of 224 tuberous sclerosis patients indicates increasedseverity of TSC2,compared with TSC1,disease in multiple organs显示文摘Dabora SL Jozwiak S Franz DN 2001Am J Hum Genet2001,68,1:1
20Efficacy and safety of everolimus for subependymal giant cell astro- cytomas associated with tuberous sclerosis complex (EXIST-l): a multicentre, randomised, placebo-controlled phase 3 trial 显示文摘Franz DN Belousova E Sparagana S et o1 2013Lancet2013,381,986:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费